Corporate Banner
Satellite Banner
Molecular & Clinical Diagnostics
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

BIOTRONIK Celebrates 50th Anniversary at Heart Rhythm Congress 2013

Published: Monday, October 21, 2013
Last Updated: Monday, October 21, 2013
Bookmark and Share
Company showcase a number of new innovations.

BIOTRONIK is celebrating its 50th anniversary at Heart Rhythm Congress 2013 by showcasing a number of new innovations.

BIOTRONIK has recently launched an extension of its ProMRI® technology to include full body MR scans for its dual- and single chamber pacemakers.

By combining advanced pacemaker and ICD technology with the option for patients to undergo MR scans, BIOTRONIK is the only company worldwide to allow ICD and heart failure patients (CRT-D and CRT-P) to take advantage of potentially life-saving MR scans.

The DX system
BIOTRONIK’s DX platform, which uses a single lead for complete atrial diagnostics, incorporates the benefits of both single- and dual-chamber ICDs. The DX system provides atrial information to aid in diagnostic accuracy while reducing the risk of complications associated with an additional atrial lead. It also enables early detection of atrial arrhythmia with BIOTRONIK Home Monitoring®.

The DX System - available with the recently FDA-approved Iforia 7 VR-T DX, newly CE marked high energy Idova ICD/CRT-D series and Linoxsmart S DX leads - offers the unique advantages of both single and dual-chamber ICDs.

The use of dual-chamber devices in patients without a clear indication for the use of an additional atrial lead has received a great deal of attention over the past few years. The DX System virtually eliminates this issue, representing a new paradigm in ICD therapy that fills a critical clinical need.

“Throughout our 50-year history, our goal has been to develop the most innovative technology on the market, ensuring physicians and their patients have access to cutting-edge therapies”, said Dr Michael Kipping, Director Sales & Marketing, BIOTRONIK UK & Ireland. “With innovations like ProMRI, DX and CLS we have proven our ability to make a real difference in patients’ lives and live up to our global reputation for excellence.”

Closed Loop Stimulation
CLS Technology - unique to BIOTRONIK pacemakers - is the only sensor system in the world that can trigger changes in heart rate in order to optimize cardiovascular flow not only based on physical activity, but also based on acute mental excitement or stress.

Closed Loop Stimulation is a unique physiologic technology of rate-adaptive pacing. It is the only sensor system in the world that can trigger changes in heart rate to optimize cardiovascular flow during mental excitement or stress.

CLS integrates into the natural cardiovascular control system and determines the appropriate heart rate based on intracardiac impedance measurements. These measurements reflect changes of the cardiac contraction dynamics in reaction to information coming from the autonomic nervous system.

CLS is available for selected BIOTRONIK pacemakers, including ones featuring the original BIOTRONIK Home Monitoring® service.


Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,500+ scientific posters on ePosters
  • More than 3,700+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

FDA Approves First Single-Lead ICD with Atrial Sensing
BIOTRONIK’s Lumax DX system could help the 50,000 patients each year who may benefit from atrial sensing, without pacing indication.
Tuesday, September 17, 2013
Scientific News
Liquid Biopsies: Utilization of Circulating Biomarkers for Minimally Invasive Diagnostics Development
Market Trends in Biofluid-based Liquid Biopsies: Deploying Circulating Biomarkers in the Clinic. Enal Razvi, Ph.D., Managing Director, Select Biosciences, Inc.
Lab-on-a-Chip Offers Promise for TB and Asthma Patients
A device to mix liquids using ultrasonics is the first and most difficult component in a miniaturized system for low-cost analysis of sputum from patients with pulmonary diseases such as tuberculosis and asthma.
Watching a Tumour Grow in Real-Time
Researchers from the University of Freiburg have gained new insight into the phases of breast cancer growth.
Urine Proteins Point to Early-Stage Pancreatic Cancer
A combination of three proteins found at high levels in urine can accurately detect early-stage pancreatic cancer, researchers at the BCI have shown.
Ultrafast DNA Diagnostics
New technology developed by UC Berkeley bioengineers promises to make a workhorse lab tool cheaper, more portable and many times faster by accelerating the heating and cooling of genetic samples with the switch of a light.
Long Telomeres Associated with Increased Lung Cancer Risk
Genetic predisposition for long telomeres predicts increased lung adenocarcinoma risk.
Paving the way to Better Ovarian Cancer Diagnosis
Aïcha BenTaieb will present her invention for automated identification of ovarian cancer’s many subtypes at an international conference this fall.
The Genetic Roots of Adolescent Scoliosis
Scientists at the RIKEN Center for Integrative Medical Sciences in collaboration with Keio University in Japan have discovered a gene that is linked to susceptibility of Scoliosis.
Diagnostic Test Developed for Enterovirus D68
researchers at Washington University School of Medicine in St. Louis have developed a diagnostic test to quickly detect enterovirus D68 (EV-D68), a respiratory virus that caused unusually severe illness in children last year.
Tracking Breast Cancer Before it Grows
A team of scientists led by University of Saskatchewan researcher Saroj Kumar is using cutting-edge Canadian Light Source techniques to screen and treat breast cancer at its earliest changes.
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,700+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!